Literature DB >> 9346650

Sanctuary of hepatitis B virus in bone-marrow cells of patients undergoing liver transplantation.

Y Ilan1, E Galun, A Nagler, Y Baruch, N Livni, R Tur-Kaspa.   

Abstract

Hepatitis B virus (HBV) reinfection after liver transplantation is a major problem. HBV is mainly a hepatotrophic virus but replicates in many extrahepatic tissues. We present here two cases of infected patients who underwent liver transplantation. Both underwent bone marrow (BM) and liver biopsies after transplantation. Biopsy specimens were stained for hepatitis B surface antigen (HB-sAg), and bone marrow aspirates and were separated for all subsets of cells. In both cases, HBV DNA analysis detected DNA in all BM fractions after transplantation, but HBV recurrence was found only in one case. We suggest that graft reinfection after liver transplantation may be caused by active replication of HBV in extrahepatic tissues and that BM cells are probably one of the major sanctuaries. The use of immunoprophylaxis based on BM-HBV studies is discussed.

Entities:  

Mesh:

Year:  1996        PMID: 9346650     DOI: 10.1002/lt.500020306

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  3 in total

Review 1.  Hepatitis B virus infection in liver transplant candidates and recipients.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  MedGenMed       Date:  2005-04-18

Review 2.  Management of chronic hepatitis B before and after liver transplantation.

Authors:  James Fung
Journal:  World J Hepatol       Date:  2015-06-08

3.  Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area.

Authors:  Yibo Wu; Yi Chen; Panpan Zhu; Baodong Ye; Ying Lu; Jimin Shi; Yamin Tan; Yanmin Zhao; Jian Yu; Xiaoyu Lai; Jianping Lan; Ting Si; Lihong Ni; He Huang; Yi Luo
Journal:  Ann Hematol       Date:  2022-01-04       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.